The global adult diaper market is expected to grow at a CAGR of around 8.5% during 2023-2030.
Companies Mentioned
Abena A/S
Attends Healthcare Group Ltd
Daio Paper Corporation
DSG International
Essity
First Quality Enterprises
Kimberly-Clark Corporation,
Paul Hartmann AG
Svenska Cellulosa Aktiebolaget (SCA)
Unicharm Corporation
Unique Wellness
Vora Global
This report on global adult diaper market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.
The report presents a clear picture of the global adult diaper market by segmenting the market based on type, product type, material, end user, distribution channel and region.
Also, detailed profiles of companies operating in the adult diaper market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Dynamics
Drivers
Growing Prevalence of Urinary Incontinence Amongst Geriatric Population
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...